Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine
about
Pharmacotherapy of Attention-Deficit Hyperactivity Disorder in AdolescentsAmphetamine, past and present--a pharmacological and clinical perspectiveLisdexamfetamine Dimesylate: Prodrug Delivery, Amphetamine Exposure and Duration of EfficacyLong-acting stimulants for treatment of attention-deficit/hyperactivity disorder: a focus on extended-release formulations and the prodrug lisdexamfetamine dimesylate to address continuing clinical challengesUpdate on optimal use of lisdexamfetamine in the treatment of ADHD.A Phase 3, Multicenter, Open-Label, 12-Month Extension Safety and Tolerability Trial of Lisdexamfetamine Dimesylate in Adults With Binge Eating DisorderA systematic review of the safety of lisdexamfetamine dimesylate.Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design.Lisdexamfetamine dimesylate: a new therapeutic option for attention-deficit hyperactivity disorder.Focus on Lisdexamfetamine: A Review of its use in Child and Adolescent Psychiatry.Executive function deficits in children with attention-deficit/hyperactivity disorder and improvement with lisdexamfetamine dimesylate in an open-label study.Wake-promoting pharmacotherapy for psychiatric disorders.Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: sex and age effects and effect size across the day.Efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder previously treated with amphetamines: analyses from a randomized, double-blind, multicenter, placebo-controlled titration study.Health-related quality of life and functional outcomes from a randomized-withdrawal study of long-term lisdexamfetamine dimesylate treatment in children and adolescents with attention-deficit/hyperactivity disorder.Investigational drugs for schizophrenia targeting the dopamine receptor: phase II trials.Efficacy of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder previously treated with methylphenidate: a post hoc analysisPreclinical Evidences for an Antimanic Effect of Carvedilol.Preclinical Assessment of Lisdexamfetamine as an Agonist Medication Candidate for Cocaine Addiction: Effects in Rhesus Monkeys Trained to Discriminate Cocaine or to Self-Administer Cocaine in a Cocaine Versus Food Choice Procedure.Lisdexamfetamine Dimesylate Effects on the Pharmacokinetics of Cytochrome P450 Substrates in Healthy Adults in an Open-Label, Randomized, Crossover StudyTreating attention-deficit/hyperactivity disorder in adults: focus on once-daily medications.Pilot study of the effects of lisdexamfetamine on cocaine use: A randomized, double-blind, placebo-controlled trialMethod validation and determination of lisdexamfetamine and amphetamine in oral fluid, plasma and urine by LC-MS/MS.Study protocol: a dose-escalating, phase-2 study of oral lisdexamfetamine in adults with methamphetamine dependenceAdolescent D-amphetamine treatment in a rodent model of ADHD: Pro-cognitive effects in adolescence without an impact on cocaine cue reactivity in adulthood.Double-blind, placebo-controlled, two-period, crossover trial to examine the pharmacokinetics of lisdexamfetamine dimesylate in healthy older adults.Lisdexamfetamine Dimesylate for Adults with Moderate to Severe Binge Eating Disorder: Results of Two Pivotal Phase 3 Randomized Controlled Trials.An open-label investigation of the pharmacokinetic profiles of lisdexamfetamine dimesylate and venlafaxine extended-release, administered alone and in combination, in healthy adults.Combining Stimulants and Monoamine Oxidase Inhibitors: A Reexamination of the Literature and a Report of a New Treatment Combination.Attenuation of cocaine self-administration by chronic oral phendimetrazine in rhesus monkeysEfficacy and safety of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder and recent methylphenidate use.Pharmacokinetics of coadministered guanfacine extended release and lisdexamfetamine dimesylate.A Single-Dose, Open-Label Study of the Pharmacokinetics, Safety, and Tolerability of Lisdexamfetamine Dimesylate in Individuals With Normal and Impaired Renal Function.A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents.Longitudinal magnetic resonance imaging reveals striatal hypertrophy in a rat model of long-term stimulant treatment.Efficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit/hyperactivity disorder: a head-to-head, randomized, double-blind, phase IIIb study.Relative Bioavailabilities of Lisdexamfetamine Dimesylate and D-Amphetamine in Healthy Adults in an Open-Label, Randomized, Crossover Study After Mixing Lisdexamfetamine Dimesylate With Food or DrinkLisdexamfetamine in the treatment of adolescents and children with attention-deficit/hyperactivity disorder.Efficacy of lisdexamfetamine dimesylate throughout the day in children and adolescents with attention-deficit/hyperactivity disorder: results from a randomized, controlled trial.Methylphenidate transdermal system: clinical applications for attention-deficit/hyperactivity disorder.
P2860
Q22241419-B2BA06FB-D8A5-4777-981A-8C68F8166F90Q22241826-A12F42FC-E939-439A-9D43-C68DFAF501EDQ26750486-B35A1A14-7653-40D1-A8E0-61E302D937E4Q26822392-3DB2F59F-D5E8-4690-BC4B-6CA01E365367Q30418053-DC588417-A8D4-43E2-B104-B69CE84D5345Q33590913-A407919E-FFE9-4074-9371-C379788F454CQ33755396-D177C83C-A123-4B8F-842A-5E302C242DA1Q34011677-CFF247DB-41C2-47AD-A46E-345604F52759Q34032634-D93C8D14-91A0-48BD-8F41-5581C39D0E4AQ34232286-68799682-391C-4C59-974E-559334511A9FQ34421050-36234C9B-501C-499C-AFEC-1FE05074DBC1Q34443394-F938D3D1-D113-49D3-A296-C00C8F3AB0FEQ34498667-CF4DAD6F-A15A-438A-BE24-AD318B702687Q34518522-65753140-A1FA-4BE1-A127-CB2435B55F59Q34580471-8FF8F257-3562-4CF5-9035-2148D78143C1Q34703195-B5EDF2FE-D881-4C9D-BC72-C1E60730FC48Q35576553-DF0A9C7F-6EC4-47C4-B1B9-17D1851C94D9Q35657017-8A25898B-131E-4116-B2D1-531C8B6FAA6CQ35691213-D02A03A9-98DF-4878-B42E-388556E7D448Q35807351-4F8190EB-FBDA-4F1F-A003-9273667E7327Q35833310-D0C0FA48-8299-4AFF-A5E4-5D1863DBB23EQ35875805-C43D183E-F2F8-4684-961A-8717AF846B4BQ36102896-360E0112-BF90-49EA-94E1-BB4BEA03F17CQ36209156-FC397584-FF34-4088-ABB9-F60F735650CFQ36372705-EF947F99-6A60-4034-ADDD-9D7CAC8C2E30Q36618017-BA0B9BBC-CA70-49BD-9156-5B140ED6CB5DQ36690648-CFA1F08A-D02A-4CD6-A6C6-9622727C7327Q36718468-730F3F97-D3CD-45F5-8B84-8FAC7D15DD22Q36722925-71812B13-58B7-4170-BBFE-915F1CE6F7B0Q36818345-7F190E1E-C207-4AEB-BEED-28168F5C96C6Q36923591-0BBE69E9-25D1-428E-8175-2B2B62775406Q36947618-F9E4961D-9E01-4CEB-ABB2-9F8653302CAEQ37104132-883CFEFD-B0AF-471F-87F5-05776DC4BFCFQ37115696-57E8C0A1-8AD5-4EF9-BA71-7C02944F5B30Q37307186-496C9BD2-EAD4-42F4-AD7B-841570F63C32Q37330660-6455129B-EC69-48DD-934A-BCEE9E899FF2Q37506129-74696EFB-0BE7-496B-9694-33D003C6971CQ37561623-9CE8CA8D-A402-4A75-9C57-467800D465FBQ37568899-F0B904D1-C277-4CB2-896F-04857B9DFE85Q37960505-F87A1998-183E-4F80-A754-15FBE116EADE
P2860
Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine
@ast
Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine
@en
type
label
Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine
@ast
Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine
@en
prefLabel
Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine
@ast
Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine
@en
P2860
P356
P1476
Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine
@en
P2093
Michael Pennick
P2860
P304
P356
10.2147/NDT.S9749
P407
P577
2010-06-24T00:00:00Z